Literature DB >> 30105120

Multiple Hereditary Exostoses: Report of an EXT2 Gene Mutation in a Colombian Family.

Jhon Camacho1, Luz Dary Gutierrez2, Cladelis Rubio2, Alfonso Suárez2, Angie Amaya3.   

Abstract

Multiple hereditary exostoses (MHE) is a rare disease with autosomal dominant inheritance, caused by heterozygous germline mutations in the EXT1 or EXT2 genes. This disorder is characterized by the growth of prominences surrounded by cartilage in the growth plates and the long bones. Here, we report a family affected by MHE. In this family, a pathogenic variant c.544C > T (p. Arg182Ter) was identified in the EXT2 gene. This variant has been previously described in the literature, and here we are reporting the relationship with clinical findings. MHE is suspected according to the clinical manifestations; molecular research should be performed to establish the most frequent mutations. A support, diagnosis, and follow-up group should be created, and genetic counseling should be available for patients and families.

Entities:  

Keywords:  EXT1; EXT2; children; hereditary multiple exostoses; osteochondroma

Year:  2018        PMID: 30105120      PMCID: PMC6087478          DOI: 10.1055/s-0038-1636998

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  13 in total

1.  Clinical and molecular studies of EXT1/EXT2 in Bulgaria.

Authors:  Malina Kirilova Stancheva-Ivanova; Wim Wuyts; Els van Hul; Briguita Ivanova Radeva; Radoslava Vasileva Vazharova; Todor Petrov Sokolov; Borislav Yordanov Vladimirov; Margarita Dimitrova Apostolova; Ivo Marinov Kremensky
Journal:  J Inherit Metab Dis       Date:  2011-04-16       Impact factor: 4.982

Review 2.  Spontaneous resolution of a solitary osteochondroma of the distal femur: a case report and review of the literature.

Authors:  Christopher E Hill; Lenetta Boyce; Irene D van der Ploeg
Journal:  J Pediatr Orthop B       Date:  2014-01       Impact factor: 1.041

Review 3.  Glycobiology and the growth plate: current concepts in multiple hereditary exostoses.

Authors:  Kevin B Jones
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

4.  Novel and recurrent mutations in the EXT1 and EXT2 genes in Chinese kindreds with multiple osteochondromas.

Authors:  Yuhong Wu; Xuesha Xing; Shaonian Xu; Hongwei Ma; Lihua Cao; Shusen Wang; Yang Luo
Journal:  J Orthop Res       Date:  2013-04-29       Impact factor: 3.494

5.  Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.

Authors:  Anne Q Phan; Maurizio Pacifici; Jeffrey D Esko
Journal:  Connect Tissue Res       Date:  2017-11-03       Impact factor: 3.417

Review 6.  Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.

Authors:  Maurizio Pacifici
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

7.  Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study.

Authors:  D E Porter; L Lonie; M Fraser; C Dobson-Stone; J R Porter; A P Monaco; A H R W Simpson
Journal:  J Bone Joint Surg Br       Date:  2004-09

Review 8.  Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).

Authors:  Ivy Jennes; Elena Pedrini; Monia Zuntini; Marina Mordenti; Sahila Balkassmi; Carla G Asteggiano; Brett Casey; Bert Bakker; Luca Sangiorgi; Wim Wuyts
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

9.  Hereditary multiple exostoses: one center's experience and review of etiology.

Authors:  K A Pierz; J R Stieber; K Kusumi; J P Dormans
Journal:  Clin Orthop Relat Res       Date:  2002-08       Impact factor: 4.176

10.  Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.

Authors:  Ivy Jennes; Danielle de Jong; Kirsten Mees; Pancras C W Hogendoorn; Karoly Szuhai; Wim Wuyts
Journal:  BMC Med Genet       Date:  2011-06-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.